|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Devic's disease:bridging the gap between laboratory and clinic显示文摘 | Cold R Linington C | 2002 | Brain2002，125，： | 1 |
| 2 | Locally advanced breast cancer显示文摘 | Jorgensen J Cold S Kamby C | 2007 | Ugeskr Laeger2007，169，37： | 1 |
| 3 | Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis 显示文摘 | Heesen C Cold SM Huitinga t | 2007 | Psychoneuroendocrinology2007，32，6： | 1 |
| 4 | elegans and is regulated by the lin-4 RNA显示文摘 | Moss EG LeeRC Ambros V The cold shock domain protein LIN-28control development timing in C | 1997 | Cell1997，88，5： | 1 |
| 5 | elegans and Is Regulated by the lin-4 RNA显示文摘 | Moss EG Lee RC Ambros V The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C | 1997 | Cell1997，88，1997： | 1 |
| 6 | Reconnecting Cities to the Biosphere: Stewardship of Green Infrastructure and Urban Ecosystem Service 显示文摘 | Andersson E Barthel S Borgstrom S Colding J Elmqvist T Folke C Gren A | 2014 | AMBIO2014，43，： | 1 |
| 7 | 5 kDa and of the Major Cold Shock Protein by Streptococcus thermophilus After Cold Shock显示文摘 | PERRIN C GUIMONT C BRACQUART P et aL Expression of a New Cold Shock Protein of 21 | 1999 | Current Mi- crobiology1999，，： | 1 |
| 8 | Locally advanced breast cancer 显示文摘 | Jorgensen J Cold S Kamby C | 2007 | Ugeskr Laeger2007，169，37： | 1 |
| 9 | RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase显示文摘 | Tuerk C MacDougal S Cold L | 1992 | Proc Natl Acad Sei USA1992，89，15： | 1 |
| 10 | The concepts of stress and stress system discorders显示文摘 | HRONSOS C P COLD P W | 1992 | JAMA1992，267，： | 1 |
| 11 | A global kinetic spatial data struc ture for a marine simulation显示文摘 | MOSTAFAVI A COLD C | 2004 | International Journal of Geographical Information Science2004，18，3： | 1 |
| 12 | Theprepuce显示文摘 | COLD C J TAYLOR J R | 1999 | Br J Urol1999，，： | 1 |
| 13 | Primary inoperable breast canc-er 显示文摘 | Jorgensen J Cold S Kamby C | 2007 | Ugeskr Laeger2007，169，37： | 1 |
| 14 | Surveyed opinion of american trauma surgeons on the prevention of the abdominal compartment syndrome显示文摘 | MAYBERRY J C COLD MAN R K MULLINS R J | 1999 | J Trauma1999，47，3： | 1 |
| 15 | Rediscovery of TraditionalEcological Knowledge As Adaptive Management显示文摘 | Berkes F Colding J Folke C | 2000 | Ecological applications2000，，5： | 1 |
| 16 | A digital frequency synthesizer 显示文摘 | TIERNEY J RADER C M COLD B | 1971 | IEEE Trans Audio Electroacoust1971，19，1： | 1 |
| 17 | The prepuce显示文摘 | Cold C J Taylor J R | 1999 | B J Urol1999，83，1： | 1 |
| 18 | Neuroblastoma in a 17-week fetus: a stimulus for investigation of tumors in a series of 2786 stillbirth and late miscarriages显示文摘 | MePherson E Cold C Johnson P | 2015 | Am J Med Genet A2015，167，1： | 1 |
| 19 | Fecal microbiota transplantation for the treatment of irritable bowel syndrome:A systematic review and meta-analysis显示文摘BACKGROUND Irritable bowel syndrome(IBS)is the most prevalent gastrointestinal disorder in developed countries and reduces patients’quality of life,hinders their ability to work,and increases health care costs.A growing number of trials have demonstrated an aberrant gut microbiota composition in IBS,also known as‘gut dysbiosis’.Fecal microbiota transplantation(FMT)has been suggested as a treatment for IBS.AIM To assess the efficacy and safety of FMT for the treatment of IBS.METHODS We searched Cochrane Central,MEDLINE,EMBASE and Web of Science up to 24 October 2022 for randomised controlled trials(RCTs)investigating the effectiveness of FMT compared to placebo(including autologous FMT)in treating IBS.The primary outcome was the number of patients with improvements of symptoms measured using a validated,global IBS symptoms score.Secondary outcomes were changes in quality-of-life scores,non-serious and serious adverse events.Risk ratios(RR)and corresponding 95%CI were calculated for dichotomous outcomes,as were the mean differences(MD)and 95%CI for continuous outcomes.The Cochrane risk of bias tool was used to assess the quality of the trials.GRADE criteria were used to assess the overall quality of the evidence.RESULTS Eight RCTs(484 participants)were included in the review.FMT resulted in no significant benefit in IBS symptoms three months after treatment compared to placebo(RR 1.19,95%CI:0.68-2.10).Adverse events were reported in 97 participants in the FMT group and in 45 participants in the placebo group(RR 1.17,95%CI:0.63-2.15).One serious adverse event occurred in the FMT group and two in the placebo group(RR 0.42,95%CI:0.07-2.60).Endoscopic FMT delivery resulted in a significant improvement in symptoms,while capsules did not.FMT did not improve the quality of life of IBS patients but,instead,appeared to reduce it,albeit non significantly(MD-6.30,95%CI:-13.39-0.79).The overall quality of the evidence was low due to moderate-high inconsistency,the small number of patients in the studies,and imprecision.CONCLUSION We found insufficient evidence to support or refute the use of FMT for IBS.Larger trials are needed. | Sofie Ingdam Halkjaer Bobby Lo Frederik Cold Alice Hojer Christensen Savanne Holster Julia Konig Robert Jan Brummer Olga C Aroniadis Perttu Lahtinen Tom Holvoet Lise Lotte Gluud Andreas Munk Petersen | 2023 | World Journal of Gastroenterology2023，29，20： | 1 |
| 20 | The additional therapeutic effect of group music therapy for sehizophrenic patients:a randomized study 显示文摘 | Ulrich G Houtmans T Cold C | 2007 | Acts Psychiatr Seand2007，116，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员